26.01.2017 • News

LyondellBasell Completes US Ethylene Expansion

(c) LyondellBasell
(c) LyondellBasell

Netherlands-headquartered, Texas, USA-managed petrochemicals and plastics producer LyondellBasell has completed its 50% expansion of ethylene capacity at Corpus Christi, Texas, USA,  to 1.13 million t/y from 770,000 t/y. The commissioning of the new capacity concludes a multi-year plan launched in 2012 to lift overall US ethylene production by more than 900,000 t/y. Output capability has been beefed up at plants in Clinton, Illinois, Marion, Iowa, and Channelview, La Porte and Matagorda, Texas, to the tune of altogether $2 billion.

"As we look to meet growing, global demand for our products, we continue to seek the right opportunities that ensure we are well positioned for the longer term," said CEO Bob Patel. "By expanding ethylene capacity in the US through debottlenecks rather than long and costly greenfield developments, we quickly added substantial capacity for significantly less than the cost of a new plant."

The company has also announced plans to invest another $3 billion in the Gulf region. New projects include a new HDPE plant in La Porte, Texas, which will be the first to use its new Hyperzone technology. Construction on the facility planned to go on stream in 2019 is scheduled to start in the near future. LyondellBasell also plans to build a world-scale propylene oxide/tertiary butyl alcohol (PO/TBA) plant at Channelview.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read